Bone health in patients with inborn errors of metabolism

por Langeveld, M., Hollak, C. E. M.
Publicado 2018

The quality of economic evaluations of ultra-orphan drugs in Europe – a systematic review

por Schuller, Y., Hollak, C. E. M., Biegstraaten, M.
Publicado 2015

Pain management strategies for neuropathic pain in Fabry disease - a systematic review

por Schuller, Y., Linthorst, G. E., Hollak, C. E. M., Van Schaik, I. N., Biegstraaten, M.
Publicado 2016

Erratum to: Pain management strategies for neuropathic pain in Fabry disease - a systematic review

por Schuller, Y., Linthorst, G.E., Hollak, C.E.M., Van Schaik, I.N., Biegstraaten, M.
Publicado 2016

Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases

por Schuller, Y., Hollak, C. E. M., Gispen-de Wied, C. C., Stoyanova-Beninska, V., Biegstraaten, M.
Publicado 2017

Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries

por Post, H.C., Schutte, T., van Oijen, M.G.H., van Laarhoven, H.W.M., Hollak, C.E.M.
Publicado 2023

Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature

por de Fost, M., Out, T. A., de Wilde, F. A., Tjin, E. P. M., Pals, S. T., van Oers, M. H. J., Boot, R. G., Aerts, J. F. M. G., Maas, M., vom Dahl, S., Hollak, C. E. M.
Publicado 2008